These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infectious agents, inflammation, and growth factors: how do they interact in the progression or stabilization of mild human atherosclerotic lesions? Góis J, Higuchi M, Reis M, Diament J, Sousa J, Ramires J, Oliveira S. Ann Vasc Surg; 2006 Sep; 20(5):638-45. PubMed ID: 16983590 [Abstract] [Full Text] [Related]
8. Pathogenetic role of Chlamydia pneumoniae in calcific aortic stenosis: immunohistochemistry study and review of the literature. Kaden JJ, Bickelhaupt S, Grobholz R, Brueckmann M, Haase KK, Dempfle CE, Borggrefe M. J Heart Valve Dis; 2003 Jul; 12(4):447-53. PubMed ID: 12918845 [Abstract] [Full Text] [Related]
9. Failure to detect Chlamydia pneumoniae in senile calcific aortic stenosis or calcified congenital bicuspid aortic valve by immunofluorescence, polymerase chain reaction and electron microscopy. Rose AG. Cardiovasc Pathol; 2002 Jul; 11(5):300-4. PubMed ID: 12361842 [Abstract] [Full Text] [Related]
10. Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms. Pires LJ, Gutierrez PS. Rev Bras Cir Cardiovasc; 2007 Jul; 22(3):322-31. PubMed ID: 18157418 [Abstract] [Full Text] [Related]
11. Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection? Juvonen J, Juvonen T, Laurila A, Kuusisto J, Alarakkola E, Särkioja T, Bodian CA, Kairaluoma MI, Saikku P. Ann Intern Med; 1998 May 01; 128(9):741-4. PubMed ID: 9556468 [Abstract] [Full Text] [Related]
12. [Chlamydia pneumoniae--a new risk factor for calcific aortic stenosis?]. Kaden JJ, Haghi D, Vocke DC, Brueckmann M, Süselbeck T, Borggrefe M. Med Klin (Munich); 2005 Jun 15; 100(6):334-9. PubMed ID: 15968485 [Abstract] [Full Text] [Related]
13. Presence of Chlamydophila pneumoniae DNA but not mRNA in stenotic aortic heart valves. Edvinsson M, Hjelm E, Thelin S, Friman G, Nyström-Rosander C. Int J Cardiol; 2010 Aug 06; 143(1):57-62. PubMed ID: 19246110 [Abstract] [Full Text] [Related]
14. Infectious agents is a risk factor for myxomatous mitral valve degeneration: A case control study. Tiveron MG, Pomerantzeff PMA, de Lourdes Higuchi M, Reis MM, de Jesus Pereira J, Kawakami JT, Ikegami RN, de Almeida Brandao CM, Jatene FB. BMC Infect Dis; 2017 Apr 21; 17(1):297. PubMed ID: 28431520 [Abstract] [Full Text] [Related]
15. Do Archaea and bacteria co-infection have a role in the pathogenesis of chronic chagasic cardiopathy? Higuchi Mde L, Kawakami J, Ikegami R, Clementino MB, Kawamoto FM, Reis MM, Bocchi E. Mem Inst Oswaldo Cruz; 2009 Jul 21; 104 Suppl 1():199-207. PubMed ID: 19753475 [Abstract] [Full Text] [Related]
16. Co-infection ratios versus inflammation, growth factors and progression of early atheromas. Higuchi ML, Góis JM, Reis MM, Higuchi-Dos-Santos MH, Diament J, Sousa JM, Ramires JA, Oliveira SA. APMIS; 2006 May 21; 114(5):338-44. PubMed ID: 16725009 [Abstract] [Full Text] [Related]
17. Microorganisms and valve tissue/ demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cytomegalovirus, and Epstein-Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumatic stenotic mitral valves by polymerase chain reaction. Davutoğlu V, Ercan S, Oylumlu M. Anadolu Kardiyol Derg; 2011 Sep 21; 11(6):564; author reply 564-5. PubMed ID: 21827993 [No Abstract] [Full Text] [Related]